Therapeutic KCl Transdermal Patch from Japan
Transdermal patch system delivering potassium chloride continuously over 24 hours for patients with swallowing difficulties needing electrolyte maintenance. HTS 3004.90.92.65 includes transdermal systems per heading description, put up for retail sale affecting water balance. Non-invasive alternative to oral dosing.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Adhesive performance and permeation rate studies mandatory
• Controlled substance monitoring if combined with other APIs